Dr. Atul Humar
Medical Director - Transplant | University Health Network
Toronto, ON, CANADA
An internationally recognized expert in transplant infectious disease
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
Dr. Atul Humar is a Professor in the Department of Medicine, University of Toronto. Dr. Humar received his medical degree from the University of Ottawa. He completed his residency and did further training in Transplant Infectious Diseases in Toronto and Boston. Dr. Humar’s research interests are in virology with a focus on the pathogenesis of herpesvirus infections post-transplant. He is involved in both basic and clinical research assessing immunologic and virologic determinants of infection. Dr. Humar is the Director of Multi Organ Transplant Program at the University Health Network and the University of Toronto Transplant Institute.
Industry Expertise (5)
Health Care - Services
Health Care - Providers
Health Care - Facilities
Health and Wellness
Research
Areas of Expertise (7)
Emerging Viral Infections
Organ Transplant
Infectious Diseases
Post-Transplant Herpesvirus Infections
Cmv Molecular Diagnostics
Host Responses to Cmv
Prevention and Management Strategies
Education (3)
University of Toronto: Fellowship, Infectious Diseases
University of Ottawa: Residency, Internal Medicine
University of Ottawa: MD, Medicine
Affiliations (3)
- UHN, Multi-Organ Transplant Program : Director
- University of Toronto : Director, Transplantation Institute
- University of Toronto : Professor, Department of Medicine
Media Appearances (5)
Understanding organ donation: Q & A with Dr. Atul Humar
University of Toronto News online
2014-01-15
Every three days in Ontario, someone dies waiting for an organ transplant. Transplant medicine has grown by leaps and bounds in the last decade, but the supply of organs and tissue has not kept pace with demand. Toronto, in particular, has some of the lowest donor registration rates in Canada...
Toronto General Hospital gets new head of transplant program
The Toronto Star online
2013-09-18
When the SARS outbreak hit Toronto in 2002, organ transplant doctors at Toronto General Hospital had to decide whether to cancel or carry on with the life-saving procedures. They decided to continue, largely due to the presence of Dr. Atul Humar, an infectious disease specialist, then with the program...
Transplant Infectious Disease Expert Returns 'Home'
UHN online
2013-08-10
For the newest leader of University Health Network’s Multi-Organ Transplant Program, UHN is a comfortable place to be. “In many ways, it feels like I’m coming back home,” said Dr. Atul Humar, the newly appointed Medical Director of UHN’s Multi-Organ Transplant (MOT) Program, who was selected for the job following anextensive worldwide search. After spending six years in Edmonton, most recently as Professor in the Department of Medicine at the University of Alberta and Director of the Alberta Transplant Institute, which he established, Humar has returned to UHN...
A Homecoming: Question and Answer with... Dr. Atul Humar
UHN online
2013-09-01
This September, Dr. Atul Humar succeeded his mentor, Dr. Gary Levy, as Medical Director of UHN’s Multi-Organ Transplant Program. He has received numerous awards including Canada’s Top 40 under 40...
Power Couples: Deepali Kumar & Atul Humar
Avenue Edmonton online
2012-04-30
Forget the stock market, politics or piracy; medical science is one of the most cutthroat professions in the world. But doctors Atul Humar and Deepali Kumar, both infectious-disease physicians and researchers at the University of Alberta, have a secret: Each other...
Articles (5)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Transplantation
2010-01-01
Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on ...
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
American Journal of Transplantation
2007-01-01
Oral valganciclovir shows comparable safety and is not inferior to iv ganciclovir for treatment of cytomegalovirus disease in organ transplant recipients and provides a simpler treatment strategy, but care should be taken in extrapolating to organ transplant recipients not ...
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
American Journal of Transplantation
2004-01-01
We compared the efficacy and safety of valganciclovir with those of oral ganciclovir in preventing cytomegalovirus (CMV) disease in high-risk seronegative solid organ transplant (SOT) recipients of organs from seropositive donors (D+/R-). In this randomised, ...
Clinical Utility of Quantitative Cytomegalovirus Viral Load Determination for Predicting Cytomegalovirus Disease in Liver Transplant Recipients
Transplantation
1999-01-01
The early detection of cytomegalovirus (CMV) after liver transplantation may form the basis of a preemptive strategy for prevention of active CMV disease. Methods. We prospectively analyzed the clinical use of weekly quantitative polymerase chain reaction-( ...
Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers
The American Journal of Transplantation
1997-01-01
Imported malaria is an increasing problem worldwide. A rapid and accurate test for Plasmodium falciparum infection would facilitate the diagnosis of malaria in the returned traveler. The ParaSight F antigen capture assay (dipstick test) is a new diagnostic test for ...
Social